EFFECTS OF HISTAMINE, H-1, H-2 AND H-IC RECEPTOR ANTAGONISTS AND ALPHA-FLUOROMETHYLHISTIDINE ON THE GROWTH OF HUMAN COLORECTAL-CANCER IN THE SUBRENAL CAPSULE ASSAY
E. Suonio et al., EFFECTS OF HISTAMINE, H-1, H-2 AND H-IC RECEPTOR ANTAGONISTS AND ALPHA-FLUOROMETHYLHISTIDINE ON THE GROWTH OF HUMAN COLORECTAL-CANCER IN THE SUBRENAL CAPSULE ASSAY, Agents and actions, 41, 1994, pp. 30000118-30000120
Biogenic amines play an important role in regulating cell proliferatio
n in the normal and neoplastic colon. Elevated histidine decarboxylase
(HDC) activity has been measured in human colorectal tumors. H-2 anta
gonists can suppress the growth of colorectal cancer and their inclusi
on in human therapy has been proposed. We studied the effects of hista
mine, cimetidine, mepyramine and alpha-fluoromethylhistidine (FMH) on
the growth of colorectal tumors in ten patients in the 6-day mouse sub
renal capsule assay (SRCA). The effect of the H-ic antagonist DPPE was
tested in two assays. In summary, a reduction of tumor size was achie
ved with histamine and DPPE. In addition, significant inhibition of tu
mor growth was seen in the FMH-treated animals. When pooled by their g
rowth potential, as assessed by the growth of saline-treated controls,
FMH and DPPE caused distinct tumor reduction in rapidly growing tumor
s. In the moderately growing tumors, histamine and mepyramine were the
most effective.